Bank of America’s Zosano Pharma Corporation ZSAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-14
Closed 8955
2021
Q3
$0 Buy
14
+13
+1,300% +$337 ﹤0.01% 8606
2021
Q2
$0 Buy
+1
New +$32 ﹤0.01% 8343
2020
Q4
Sell
-6,568
Closed -$372K 7509
2020
Q3
$372K Buy
+6,568
New +$306K ﹤0.01% 4938
2020
Q2
Sell
-48
Closed -$1K 7280
2020
Q1
$1K Buy
+48
New +$1.61K ﹤0.01% 6763
2019
Q4
Sell
-24
Closed -$1K 7569
2019
Q3
$1K Buy
+24
New +$2.15K ﹤0.01% 7187
2019
Q2
Sell
-1
Closed 7529
2019
Q1
$0 Buy
+1
New +$123 ﹤0.01% 7535
2018
Q4
Sell
-39
Closed -$6K 7510
2018
Q3
$6K Buy
39
+6
+18% +$879 ﹤0.01% 6800
2018
Q2
$5K Sell
33
-24
-42% -$3.61K ﹤0.01% 6807
2018
Q1
$10K Buy
+57
New +$19.1K ﹤0.01% 6614
2017
Q2
Hold
0
7275
2017
Q1
Hold
0
7344
2016
Q4
Hold
0
7447
2016
Q3
Hold
0
7459
2016
Q2
Hold
0
7497

Other funds holding ZSAN

Bank of America's ZSAN Position: Q4 2021 in Review

Bank of America sold out of Zosano Pharma Corporation (ZSAN) in Q4 2021, closing a stake of 14 shares.

Bank of America first reported a position in ZSAN in Q1 2018 and held it in 9 quarters. The position peaked at $372K in Q3 2020. 32 funds tracked by Wall St. Rank hold ZSAN as of Q4 2021.

  • Bank of America reported no remaining Zosano Pharma Corporation position as of Q4 2021 after selling out during the quarter.
  • Bank of America sold 14 Zosano Pharma Corporation shares in Q4 2021.
  • Bank of America first reported a position in Zosano Pharma Corporation in Q1 2018 and held it in 9 quarters.
  • Bank of America's Zosano Pharma Corporation position peaked at $372K in Q3 2020.
  • 32 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q4 2021.

Based on Bank of America's 13F filing for Q4 2021, filed 8 Feb 2022.